NMTRQ
vs
AZN
NMTRQ
AZN
Over the past 12 months, NMTRQ has underperformed AZN, delivering a return of 0% compared to the AZN's +25% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
NMTRQ
AZN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
9 Meters Biopharma Inc
OTC:NMTRQ
|
0.0001
USD
|
|||||
|
AstraZeneca PLC
LSE:AZN
|
13 976
GBX
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
NMTRQ, AZN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
9 Meters Biopharma Inc
Revenue
|
|||||||||||
|
AstraZeneca PLC
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
NMTRQ, AZN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
9 Meters Biopharma Inc
OTC:NMTRQ
|
|||||||||
|
AstraZeneca PLC
LSE:AZN
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
9 Meters Biopharma Inc | ||||
|
AstraZeneca PLC | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
NMTRQ, AZN
Performance By Year
NMTRQ, AZN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.